Ledger.Open graph →
SEC Form D · filed July 17, 2024

PROVECTUS BIOPHARMACEUTICALS, INC

Offering
$10.0M
Sold
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KNOXVILLE, TN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Webster Bailey · Knoxville, TNDirectorHeather Raines · Knoxville, TNExecJohn Lacey, Iii · Knoxville, TNDirectorEric Wachter · Knoxville, TNExecDominic Rodrigues · Knoxville, TNDirectorEdward Pershing · Knoxville, TNDirectorEric Nijensohn · Hinsdale, ILDirectorWinter Richards · Santa Monica, CAExecPaolo Bertolotti · New York, NYDirectorNeil Underwood · New York, NYExecAdam Devita · New York, NYDirectorJacob Whitney · Loveland, CODirectorMia Lewin · Sammamish, WAExecAndrew P. Jacobson · Miami, FLDirectorStanley Beckley · Miami, FLDirectorJohn Delta · Miami, FLExecEdward Pershing · Knoxville, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗